Institution · Ferro Solutions (United States)

Most cited papers from Ferro Solutions (United States)

Ferro Solutions (United States)

What are the most cited papers from Ferro Solutions (United States)?

The most cited paper from Ferro Solutions (United States) is "A Comparison of the Malignancy Incidence Among Patients With Psoriatic Arthritis and Patients With Rheumatoid Arthritis in a Large US Cohort" (Rachael L. Gross, Julie S. Schwartzman-Morris, Michael Krathen et al., 2014), with 72 citations. Next come "New high-sensitivity hybrid magnetostrictive/electroactive magnetic field sensors" (67) and "Impact of prior biologic use on persistence of treatment in patients with psoriatic arthritis enrolled in the US Corrona registry" (56).

Published TypeFieldAccess

Showing 10 of 10 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	A Comparison of the Malignancy Incidence Among Patients With Psoriatic Arthritis and Patients With Rheumatoid Arthritis in a Large US Cohort Rachael L. Gross, Julie S. Schwartzman-Morris, Michael Krathen et al. · Arthritis & Rheumatology Open access	3 Mar 2014	72
2	New high-sensitivity hybrid magnetostrictive/electroactive magnetic field sensors Jiankang Huang, Robert C. O’Handley, David Bono · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE Conference paper	25 Jul 2003	67
3	Impact of prior biologic use on persistence of treatment in patients with psoriatic arthritis enrolled in the US Corrona registry Leslie R. Harrold, Bradley S. Stolshek, Sabrina Rebello et al. · Clinical Rheumatology Open access	7 Mar 2017	56
4	Frequency response of acoustic-assisted Ni–Mn–Ga ferromagnetic-shape-memory-alloy actuator Ratchatee Techapiesancharoenkij, Jari Kostamo, Samuel M. Allen et al. · Journal of Applied Physics Open access	May 2009	37
5	Understanding the association between skin involvement and joint activity in patients with psoriatic arthritis: experience from the Corrona Registry Philip J. Mease, Carol J. Etzel, William J. Huster et al. · RMD Open Open access	May 2019	31
6	Effectiveness of Rituximab for the Treatment of Rheumatoid Arthritis in Patients with Prior Exposure to Anti-TNF: Results from the CORRONA Registry Leslie R. Harrold, George W Reed, Ashwini Shewade et al. · The Journal of Rheumatology Open access	May 2015	26
7	Treatment patterns in rheumatoid arthritis patients newly initiated on biologic and conventional synthetic disease-modifying antirheumatic drug therapy and enrolled in a North American clinical registry Philip J. Mease, Scott Stryker, Mei Liu et al. · Arthritis Research & Therapy Open access	8 Sep 2021	24
8	Baseline patient characteristics associated with response to biologic therapy in patients with psoriatic arthritis enrolled in the Corrona Psoriatic Arthritis/Spondyloarthritis Registry Philip J. Mease, Chitra K. Karki, Mei Liu et al. · RMD Open Open access	Apr 2018	18
9	Wideband energy harvesting for resonant piezoelectric devices Cheng Luo, Heath F. Hofmann Conference paper	Sep 2010	8
10	Impact of incident diabetes on atherosclerotic cardiovascular disease according to statin use history among postmenopausal women Yunsheng Ma, Gioia M. Persuitte, Chris Andrews et al. · European Journal of Epidemiology Open access	17 May 2016	7

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.